Knowledge HQ

The study analyses neoantigen-specific T cells in melanoma patients. Isolated neoTCRs were engineered into donor T cells, which were expanded in 24-well G-Rex plates. The expanded cells were used to validate TCR specificity and cytotoxicity against autologous tumor cell lines.

The study isolates neutralizing human mAbs against Sosuga virus from a survivor. Hybridoma cell lines secreting these mAbs were expanded in 6-well G-Rex plates to produce sufficient antibodies for purification and subsequent functional characterization.

This study evaluates anti-CD20 pre-treatment for enhancing SIV-specific CAR-T cell therapy in macaques. CAR-T cells were manufactured using G-Rex 6-well plates for expansion. While anti-CD20 treatment increased initial CAR-T expansion, the cells failed to persist long-term, and viral loads were not significantly affected.

The paper presents a low-cost, point-of-care CAR-T manufacturing process. It uses the Sepax C-Pro for cell processing and G-Rex devices for cell expansion. The study demonstrates that this simplified workflow produces highly functional CAR-T cells, comparable to standard methods, supporting decentralized production.

This review explores the role of small extracellular vesicles (sEVs) derived from various immune cells. It highlights a protocol using G-Rex to produce and isolate large amounts of human NK cell-derived sEVs, demonstrating their potential for clinical application in cancer therapy.

This review discusses the biomanufacturing of NK cell therapies, covering cell sources, expansion methods, and process control. It identifies G-Rex as a commonly used culture system for clinical-scale NK cell production due to their gas-permeable membranes, facilitating efficient cell expansion.

The study develops an activated T cell (ATC) therapy targeting glioblastoma cancer stem cells. It compares antigen sources, finding synthetic peptide pools most effective. T cells were co-cultured with antigen-loaded dendritic cells in G-Rex 100 containers for activation and rapid proliferation over 12 days.

This study characterizes humoral and T cell responses to the BNT162b2 vaccine. It establishes a rapid 11-day ex-vivo expansion protocol for spike-specific T cells using G-Rex 10 devices, demonstrating significant fold expansion and functional enhancement for potential adoptive immunotherapy.

High-throughput screening identified a small molecule, GSK2622391, that enhances lentiviral transduction efficiency in T cells. The compound improves vector copy number without negatively impacting cell viability or function. G-Rex plates were used for T cell expansion during small-scale validation experiments.

The study shows that overexpression of an engineered PGC-1α improves the metabolic fitness and anti-tumor efficacy of CAR-T cells. During in vitro culture, cells were transferred to G-Rex 6M Well Plates for rapid expansion.

This review covers various bioreactor systems for red blood cell production. It specifically references the use of G-Rex for the expansion of peripheral blood mononuclear cells (PB MNCs) in its summary of 3D scaffolds and bioreactors.

The study demonstrates that CoStAR, a chimeric costimulatory receptor, enhances the effector function of T cells and TILs. Transgene-expressing cells and TILs were expanded using G-Rex plates, including G-Rex 6M, as part of the rapid expansion protocol.